Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Teladoc Health Inc (NYSE: TDOC) closed at $10.40 in the last session, up 3.48% from day before closing price of $10.05. In other words, the price has increased by $3.48 from its previous closing price. On the day, 3.41 million shares were traded. TDOC stock price reached its highest trading level at $10.77 during the session, while it also had its lowest trading level at $10.08.
Ratios:
We take a closer look at TDOC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.40. For the most recent quarter (mrq), Quick Ratio is recorded 1.65 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 1.05 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 15, 2024, initiated with a Buy rating and assigned the stock a target price of $14.
On September 17, 2024, Jefferies reiterated its Hold rating and also lowered its target price recommendation from $8 to $10.
On February 29, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $22.Cantor Fitzgerald initiated its Overweight rating on February 29, 2024, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 03 ’25 when Nanis Nikolaos P. bought 502 shares for $9.33 per share.
Waters Michael Willem bought 4,652 shares of TDOC for $47,823 on Dec 16 ’24. On Dec 03 ’24, another insider, Nueno Carlos, who serves as the President, International of the company, sold 2,890 shares for $11.23 each. As a result, the insider received 32,455 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TDOC now has a Market Capitalization of 1790536832 and an Enterprise Value of 2135545856. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 1.19. Its current Enterprise Value per Revenue stands at 0.825 whereas that against EBITDA is 32.266.
Stock Price History:
The Beta on a monthly basis for TDOC is 1.27, which has changed by -0.49775112 over the last 52 weeks, in comparison to a change of 0.2000997 over the same period for the S&P500. Over the past 52 weeks, TDOC has reached a high of $21.74, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is 2.80%, while the 200-Day Moving Average is calculated to be 6.79%.
Shares Statistics:
According to the various share statistics, TDOC traded on average about 4.98M shares per day over the past 3-months and 3851600 shares per day over the past 10 days. A total of 171.94M shares are outstanding, with a floating share count of 168.52M. Insiders hold about 2.12% of the company’s shares, while institutions hold 73.25% stake in the company. Shares short for TDOC as of 1736899200 were 23496534 with a Short Ratio of 4.72, compared to 1734048000 on 22711729. Therefore, it implies a Short% of Shares Outstanding of 23496534 and a Short% of Float of 17.7.
Earnings Estimates
The stock of Teladoc Health Inc (TDOC) is currently in the spotlight, with 3.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.31 and low estimates of -$0.46.
Analysts are recommending an EPS of between -$1.09 and -$1.31 for the fiscal current year, implying an average EPS of -$1.19. EPS for the following year is -$1.03, with 3.0 analysts recommending between -$0.82 and -$1.31.
Revenue Estimates
According to 25 analysts, the current quarter’s revenue is expected to be $639.44M. It ranges from a high estimate of $673.75M to a low estimate of $632.34M. As of the current estimate, Teladoc Health Inc’s year-ago sales were $660.53MFor the next quarter, 25 analysts are estimating revenue of $633.78M. There is a high estimate of $654.78M for the next quarter, whereas the lowest estimate is $620.43M.
A total of 25 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.6B, while the lowest revenue estimate was $2.56B, resulting in an average revenue estimate of $2.57B. In the same quarter a year ago, actual revenue was $2.6BBased on 25 analysts’ estimates, the company’s revenue will be $2.55B in the next fiscal year. The high estimate is $2.6B and the low estimate is $2.48B.
